stockrow
Tuesday 3 November 2026
Export NUS’s income statement to Excel — free account
Nu Skin Enterprises, Inc.
NUS Consumer Defensive Household & Personal Products
Nu Skin Enterprises, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 14.3% from fiscal 2024.
- Revenue
- −17.1%
- EPS
- −1,295.4%
- Free cash flow
- −86.1%
- Total debt
- −14.2%
Quarter to June 2026, against a year earlier
4.78
0.13
+2.80%
Follow NUS
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
14.55% | 22.00% | 7.04% | (32.53%) | |
Piotroski F-Score |
6 | 7 | 7 | 4 | |
| 7.29% | 11.15% | 3.94% | (16.87%) | ||
ROIC |
(0.85%) | 5.21% | 6.09% | (1.15%) | |
Return on Tangible Assets |
16.38% | 24.23% | 8.42% | (34.27%) | |
Average Days of Receivables |
11.44 | 9.72 | 11.40 | 12.98 | |
Free Cash Flow per Share |
1.08 | 0.93 | 0.86 | 0.22 | |
Free Cash Flow |
53.35 | 46.01 | 41.57 | 10.78 | |
Capital Expenditures |
(36.10) | (34.28) | (34.41) | (40.03) | |
| Other line items | |||||
Cash ROIC |
4.16% | 3.62% | 3.41% | 1.14% | |
Accounts Receivable Turnover |
26.51 | 32.88 | 28.37 | 25.33 | |
Accounts Payable Turnover |
16.71 | 14.86 | 14.18 | 12.76 | |
Inventory Turnover |
2.40 | 2.46 | 2.41 | 2.28 | |
Average Days of Payables |
20.34 | 21.06 | 23.77 | 32.48 | |
Days of Inventory on Hand |
127.32 | 143.70 | 147.36 | 164.94 | |
Tax Rate |
(0.09) | (0.18) | (0.15) | 7.20 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
63.33% | 63.33% | 63.65% | 64.07% | |
Share Based Compensation of Revenue |
1.56% | 1.62% | 1.28% | 1.00% | |
Interest Coverage |
(0.67) | 4.71 | 5.34 | (0.66) | |
Operating CF/Net income |
0.82 | 0.50 | 1.39 | (0.23) | |
Depreciation/Fixed assets |
0.15 | 0.14 | 0.13 | 0.13 | |
Capex/Depreciation |
(0.65) | (0.66) | (0.68) | (0.80) | |
Revenue per Share |
31.59 | 30.13 | 29.90 | 28.30 | |
Operating CF per Share |
1.81 | 1.63 | 1.58 | 1.05 | |
Capex per Share |
(0.73) | (0.70) | (0.71) | (0.82) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.03 |
Columns are period end dates